Stockscreener 앱 받기
17.69
1.17%
-0.21
시간 외 거래:
17.69
전일 마감가:
$17.90
열려 있는:
$17.77
하루 거래량:
574.23K
Relative Volume:
1.13
시가총액:
$868.04M
수익:
-
순이익/손실:
$-85.21M
주가수익비율:
-9.3598
EPS:
-1.89
순현금흐름:
$-68.53M
1주 성능:
-5.55%
1개월 성능:
-11.24%
6개월 성능:
-19.59%
1년 성능:
-18.55%
1일 변동 폭
$17.43
$18.42
1주일 범위
$17.43
$20.26
52주 변동 폭
$13.30
$30.03
Enliven Therapeutics Inc Stock (ELVN) Company Profile
명칭
Enliven Therapeutics Inc
전화
720-647-8519
주소
6200 LOOKOUT ROAD, BOULDER
ELVN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ELVN
Enliven Therapeutics Inc
|
17.69 | 1.11B | 0 | -85.21M | -68.53M | -1.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Enliven Therapeutics Inc Stock (ELVN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-16 | 개시 | Goldman | Buy |
| 2024-12-13 | 개시 | BTIG Research | Buy |
| 2024-09-09 | 개시 | H.C. Wainwright | Buy |
| 2024-06-11 | 개시 | Robert W. Baird | Outperform |
| 2024-04-09 | 개시 | Mizuho | Buy |
| 2023-03-29 | 개시 | Jefferies | Buy |
모두보기
Enliven Therapeutics Inc 주식(ELVN)의 최신 뉴스
How Enliven Therapeutics Inc. stock performs during market volatilityStock Price Prediction Using AI Tools - Newser
Using AI based signals to follow Enliven Therapeutics Inc.Short-Term Bounce Forecast for Oversold Stocks - Newser
RSI Suggests Rebound May Be Near in Enliven Therapeutics Inc.Growth Based Investment Plan Guidance Highlighted - metal.it
Enliven Therapeutics (ELVN) Projected to Post Earnings on Tuesday - Defense World
What makes Enliven Therapeutics Inc. stock price move sharplyFree Daily Top Performing Stock Insights - Newser
Brokerages Set Enliven Therapeutics, Inc. (NASDAQ:ELVN) PT at $41.20 - Defense World
Federated Hermes Inc. Has $1.36 Million Position in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World
Institutional scanner results for Enliven Therapeutics Inc.AI-Based Signal Detection for Active Traders - Newser
Will Enliven Therapeutics Inc. stock split in the near futureFree Low Risk Picks for Daily Trading - Newser
Chartists Watching For Breakout in Enliven Therapeutics Inc.Stable Entry High Return Opportunities in Focus - metal.it
Sectors Driving Future Growth for Enliven Therapeutics Inc. StockFree Smart Allocation Stock Pick Insights - Newser
Enliven Therapeutics Inc. Inches Above Key Support — Safe to HoldReliable Investment Entry Signals Confirmed by Charts - metal.it
Why is Enliven Therapeutics Inc. stock attracting strong analyst attentionBuild a portfolio that outperforms the market - Jammu Links News
What are the latest earnings results for Enliven Therapeutics Inc.Track emerging stocks with high growth potential - Jammu Links News
Should I hold or sell Enliven Therapeutics Inc. stock in 2025Achieve rapid returns with smart investment plans - Jammu Links News
What analysts say about Enliven Therapeutics Inc. stockAchieve breakthrough financial results - Jammu Links News
Is it the right time to buy Enliven Therapeutics Inc. stockDiscover high-impact investment opportunities - Jammu Links News
Is Enliven Therapeutics Inc. a good long term investmentAchieve consistent profits with proven methods - Jammu Links News
How does Enliven Therapeutics Inc. generate profit in a changing economyDynamic profit opportunities - Jammu Links News
Is Enliven Therapeutics Inc. a growth stock or a value stockGet alerts on high-potential market moves - Jammu Links News
How does Enliven Therapeutics Inc. compare to its industry peersDiscover breakthrough stocks with expert help - Jammu Links News
Does Enliven Therapeutics Inc. stock perform well during market downturnsFree AI-Backed Trading Signals - Jammu Links News
Real time social sentiment graph for Enliven Therapeutics Inc.Buy Zone Strategy with Pattern Recognition - Newser
Is Enliven Therapeutics Inc. stock overvalued or undervaluedBreakout Stocks Tracker For Consistent Profits - jammulinksnews.com
How strong is Enliven Therapeutics Inc. company’s balance sheetFree Stock Recommendation With Proven Results - jammulinksnews.com
Using economic indicators to assess Enliven Therapeutics Inc. potentialValue Holding Return Summary With Outlook - Newser
What MACD and RSI say about Enliven Therapeutics Inc.Free Quick Gain Stock Watch With Indicators - Newser
Forecasting Enliven Therapeutics Inc. price range with options dataGrowth Based Investment Plan Guidance Highlighted - metal.it
Pattern recognition hints at Enliven Therapeutics Inc. upsideOptimized Watchlist With Daily Adjustments Launched - metal.it
Published on: 2025-07-30 13:46:37 - beatles.ru
Why Enliven Therapeutics Inc. stock attracts strong analyst attentionFree Fast Entry High Potential Stock Alerts - Newser
Can volume confirm reversal in Enliven Therapeutics Inc.AI-Based Reversal Point Prediction Signal - Newser
Short Term Trend Reversal in Enliven Therapeutics Inc. PossibleTop Performing Stock Insights Released Daily - beatles.ru
Can Enliven Therapeutics Inc. rally from current levelsStock Screener With Smart Filters Highlights Top Picks - metal.it
Is Enliven Therapeutics Inc. Stock a Smart Buy in 2025 Investment Analysis InsidePortfolio Positioning Strategy With Timing - Newser
Breakout Traders Target Enliven Therapeutics Inc. on Recovery SetupBuy Signal Based on Chart Analysis Confirmed - metal.it
Can Enliven Therapeutics Inc. rally from current levels Free Real Time Alerts Based on AI Prediction - Newser
Enliven Therapeutics CFO Hohl Benjamin Buys, Sells Shares on July 28, 2025 - AInvest
Enliven Therapeutics Inc (ELVN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):